These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 4138923)

  • 21. Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
    Shah LP; Rees RC; Baldwin RW
    Br J Cancer; 1976 Jun; 33(6):577-83. PubMed ID: 181040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours.
    Baldwin RW; Glaves D; Vose BM
    Br J Cancer; 1974 Jan; 29(1):1-10. PubMed ID: 4362448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on mice of a tumor resistant strain (X-Gf). 8. Type C particles in mammary tumors of Friend leukemia virus-infected mice.
    Goldfeder A; de Harven E; Friend C
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):323-8. PubMed ID: 4327596
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the immunological response to hepatoma XXII in the inbred SZNA mice].
    Basmidzhian ME; Aleksanian IuT; Tat'ian MB
    Zh Eksp Klin Med; 1974; 14(5):19-21. PubMed ID: 4376644
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 26. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 27. Significance of serum factors modifying cellular immune responses to growing tumours.
    Baldwin RW; Price MR; Robins RA
    Br J Cancer Suppl; 1973 Aug; 1():37-47. PubMed ID: 4374231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between presence of leukemia virus in cultured cells and their immunogenicity in a leukemia isotransplant system.
    Tennant JR; Lambertenghi G; Kingsley S; de Harven E
    J Natl Cancer Inst; 1971 Oct; 47(4):781-8. PubMed ID: 4328948
    [No Abstract]   [Full Text] [Related]  

  • 29. Humoral & cell mediated immunity to leukemia specific antigens in an inbred mouse strain showing spontaneous leukemia & mammary tumors.
    Vissa B; Gangal SG
    Indian J Exp Biol; 1974 Jan; 12(1):12-4. PubMed ID: 4426641
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent studies on the assessment of cell-mediated cytotoxicity in vitro.
    Weiss DW
    Natl Cancer Inst Monogr; 1976 Nov; 44():141. PubMed ID: 67561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 33. [Development of the thymus and adrenal glands during the growth of a tumor graft in rats. Preliminary note].
    Chouroulinkov I; Gentil A; Lasne C; Grabar P
    Bull Cancer; 1967; 54(1):59-66. PubMed ID: 4293715
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells.
    Le François D; Youn JK; Belehradek J; Barski G
    J Natl Cancer Inst; 1971 May; 46(5):981-7. PubMed ID: 5157849
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro.
    Kieler J; Radzikowski C; Moore J; Ulrich K
    J Natl Cancer Inst; 1972 Feb; 48(2):393-405. PubMed ID: 4652381
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of embryonic antigens with experimentally induced hepatic lesions in the rat.
    Stanislawski-Birencwajg M; Uriel J; Grabar P
    Cancer Res; 1967 Nov; 27(11):1990-7. PubMed ID: 4294528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Importance of specific and nonspecific immunity in anti-tumor defense].
    Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour immunity in tetraparental mouse chimaeras--a review.
    Barnes RD
    Eur J Cancer (1965); 1976 Apr; 12(4):283-90. PubMed ID: 60239
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intensification of antineoplastic immunity with the use of chemical heterogenization of tumor tissue antigens].
    Korosteleva TA; Movsesian KS; Aleksanian IuT
    Zh Eksp Klin Med; 1974; 14(3):7-10. PubMed ID: 4370925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.